Stock Market Reviews

VTAK (Catheter Precision, Inc.) News

Get the latest news, insights, and market updates on VTAK (Catheter Precision, Inc.). Explore the news page 3 on MyTopStock.com for investor discussions, analysis, and real-time stock performance coverage.

• Catheter Precision, Inc. Announces First Purchase Order From University Hospital in Rennes, France
  FORT MILL, S.C., July 07, 2025 (GLOBE NEWSWIRE) -- Catheter Precision, Inc. (VTAK - NYSE/American), a US based medical device company focused on developing technologically advanced products for the cardiac electrophysiology market announced today that it has received a purchase order from Centre Hospitalier Universitaire (CHU) de Rennes. This is the first purchase order from Universite de Rennes and marks the largest purchase order for the VIVO product line to date. CHU Rennes serves almost 500,
  Jul 7, 2025 - $VTAK
• Catheter Precision, Inc.  Forms new Joint Venture Called Kardionav to Exploit patented AI Techniques to Create New VT Software platform
  New AI techniques to add to VT ablation toolsFORT MILL, S.C., June 30, 2025 (GLOBE NEWSWIRE) -- Catheter Precision, Inc. (VTAK - NYSE/American), a US based medical device company focused on developing technologically advanced products for the cardiac electrophysiology market today announced that it has formed a joint venture, named Kardionav, to pursue the latest in technology surrounding the area of ablation for ventricular tachycardia. The venture is a joint development company between VTAK an
  Jun 30, 2025 - $VTAK
• Catheter Precision (VTAK) Reports Key Progress for the LockeT Product
  FORT MILL, S.C., June 12, 2025 (GLOBE NEWSWIRE) -- Catheter Precision, Inc. (VTAK - NYSE/American), a US based medical device company focused on developing technologically advanced products for the cardiac electrophysiology market announced that LockeT sales for Q2 2025 are on track to be the highest to date. Second quarter 2025 LockeT sales are already outpacing Q2 2024 sales with a 200% increase. Catheter Precision now has several US hospitals that are on track to issue more than $100,000 in p
  Jun 12, 2025 - $VTAK
• Catheter Precision, Inc. Secures VIVO Purchase Order From Sahlgrenska University Hospital
  SUH is the Largest Hospital in Sweden and a Highly Influential Center for VT in ScandinaviaFORT MILL, S.C., June 09, 2025 (GLOBE NEWSWIRE) -- Catheter Precision, Inc. (VTAK - NYSE/American), a US based medical device company focused on developing technologically advanced products for the cardiac electrophysiology market announced receipt of the first purchase order for their VIVO product from Sweden. This newest purchase order comes from Sahlgrenska University Hospital, the largest hospital in S
  Jun 9, 2025 - $VTAK
• Catheter Precision, Inc. Receives CE Mark for LockeT
  Opens Multi-Billion Market Opportunity for the Company First Order for 100 Units Received FORT MILL, S.C., May 27, 2025 (GLOBE NEWSWIRE) -- Catheter Precision, Inc. (NYSE American: VTAK), a US based medical device company focused on developing technologically advanced products for the cardiac electrophysiology market announced that it has received CE Mark approval for LockeT, the latest advanced vascular closure device. Receipt of the CE Mark indicates compliance with European Union (EU) regulat
  May 27, 2025 - $VTAK
• Catheter Precision, Inc. Announces First Quarter 2025 Update and Financial Results
  FORT MILL, S.C., May 14, 2025 (GLOBE NEWSWIRE) -- Catheter Precision, Inc. (NYSE American: VTAK), a U.S.-based innovative medical device company focused on electrophysiology products, today announced its financial results and operational update for the period ending March 31, 2025. Highlights of the first quarter include: Commercial Endeavors Approximately 50 hospitals are currently in the process of evaluating either VIVO, LockeT or both devices demonstrating that our new sales team continues t
  May 14, 2025 - $VTAK